Morris F. White

Q: What Schools Are Affiliated With Morris F. White

Morris F. White is affiliated with the following schools: New York University, University of Illinois Chicago, University of Vermont, Yale University, Albert Einstein College of Medicine, Louisiana State University

Morris F. White's AcademicInfluence.com Rankings

Morris F. White

Philosophy

#3452

World Rank

#5580

Historical Rank

Logic

#1166

World Rank

#1848

Historical Rank

philosophy Degrees

Morris F. White

Biology

#4317

World Rank

#6452

Historical Rank

Endocrinology

#27

World Rank

#31

Historical Rank

Molecular Biology

#328

World Rank

#333

Historical Rank

Biochemistry

#436

World Rank

#516

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Morris F. White's Degrees

Doctorate Medicine Stanford University

Why Is Morris F. White Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Morris F. White's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance (1996) (2631)
Disruption of IRS-2 causes type 2 diabetes in mice (1998) (1809)
The insulin signaling system. (1994) (1654)
Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle* (2002) (1577)
Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein (1991) (1486)
Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. (1999) (1226)
The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307 * (2000) (1155)
Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action* (2002) (959)
IRS proteins and the common path to diabetes. (2002) (927)
SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2* (2002) (892)
Role of IRS-2 in insulin and cytokine signalling (1995) (892)
Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. (2005) (801)
Insulin Signaling in Health and Disease (2003) (762)
Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2 (2012) (746)
The SH2/SH3 domain‐containing protein GRB2 interacts with tyrosine‐phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. (1993) (643)
Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. (1999) (601)
The IRS-signalling system: A network of docking proteins that mediate insulin action (1998) (592)
The insulin signalling system and the IRS proteins (1997) (582)
Irs-2 coordinates Igf-1 receptor-mediated β-cell development and peripheral insulin signalling (1999) (574)
Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells (1985) (564)
The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. (2002) (541)
Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. (2001) (537)
Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity (1987) (518)
Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. (2000) (513)
cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2 (2003) (503)
Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1 (1993) (463)
IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85. (1992) (460)
Insulin Receptor Substrate-2 Deficiency Impairs Brain Growth and Promotes Tau Phosphorylation (2003) (458)
Activation of phosphatidylinositol 3-kinase by insulin. (1990) (450)
IRS-2 pathways integrate female reproduction and energy homeostasis (2000) (446)
Tumor Necrosis Factor (TNF)-α Inhibits Insulin Signaling through Stimulation of the p55 TNF Receptor and Activation of Sphingomyelinase* (1996) (425)
IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. (1993) (419)
Tyrosine Dephosphorylation and Deactivation of Insulin Receptor Substrate-1 by Protein-tyrosine Phosphatase 1B (2000) (417)
c-Jun N-terminal Kinase (JNK) Mediates Feedback Inhibition of the Insulin Signaling Cascade* (2003) (417)
A cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor. (1988) (393)
Cross-talk between the insulin and angiotensin signaling systems. (1996) (391)
The insulin receptor and the molecular mechanism of insulin action. (1988) (389)
Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. (2008) (386)
Insulin signaling meets mitochondria in metabolism (2010) (374)
Brain IRS2 Signaling Coordinates Life Span and Nutrient Homeostasis (2007) (371)
Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. (1992) (345)
Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity (1988) (339)
Insulin signal transduction and the IRS proteins. (1996) (331)
An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth (1994) (323)
The IRS-1 signaling system. (1994) (322)
cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. (2003) (320)
The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. (1998) (318)
Cyclins D2 and D1 Are Essential for Postnatal Pancreatic β-Cell Growth (2005) (314)
Expression and function of IRS-1 in insulin signal transmission. (1992) (307)
IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3'-kinase. (1993) (303)
Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. (2004) (301)
Contrasting Effects of IRS-1 Versus IRS-2 Gene Disruption on Carbohydrate and Lipid Metabolism in Vivo * (2000) (290)
Insulin-like signaling, nutrient homeostasis, and life span. (2008) (289)
Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. (1988) (279)
The IRS‐signalling system during insulin and cytokine action (1997) (278)
Foxo1 integrates insulin signaling with mitochondrial function in the liver (2009) (277)
Regulation of glucose homeostasis through a XBP-1–FoxO1 interaction (2011) (265)
Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes. (2003) (264)
Insulin receptor substrate-1 mediates phosphatidylinositol 3'-kinase and p70S6k signaling during insulin, insulin-like growth factor-1, and interleukin-4 stimulation. (1994) (258)
Growth Hormone, Interferon-γ, and Leukemia Inhibitory Factor Promoted Tyrosyl Phosphorylation of Insulin Receptor Substrate-1 (*) (1995) (256)
Insulin-like growth factor I (IGF-I)-stimulated pancreatic beta-cell growth is glucose-dependent. Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 cells. (1998) (248)
RIP-Cre Revisited, Evidence for Impairments of Pancreatic β-Cell Function* (2006) (244)
Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase (1996) (240)
The structure and function of p55PIK reveal a new regulatory subunit for phosphatidylinositol 3-kinase (1995) (234)
Regulation of Phosphatidylinositol 3′-Kinase by Tyrosyl Phosphoproteins (1995) (231)
4PS/Insulin Receptor Substrate (IRS)-2 Is the Alternative Substrate of the Insulin Receptor in IRS-1-deficient Mice (*) (1995) (229)
Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice (2005) (226)
PTB Domains of IRS-1 and Shc Have Distinct but Overlapping Binding Specificities (*) (1995) (225)
Role of IRS-1-GRB-2 complexes in insulin signaling (1994) (224)
The New Elements of Insulin Signaling: Insulin Receptor Substrate-1 and Proteins With SH2 Domains (1993) (213)
Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. (2005) (212)
Nck associates with the SH2 domain-docking protein IRS-1 in insulin-stimulated cells. (1993) (209)
Regulation of Insulin/Insulin-like Growth Factor-1 Signaling by Proteasome-mediated Degradation of Insulin Receptor Substrate-2* (2001) (200)
Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth. (2006) (196)
Interferon-α Engages the Insulin Receptor Substrate-1 to Associate with the Phosphatidylinositol 3′-Kinase (*) (1995) (194)
Phorbol esters modulate insulin receptor phosphorylation and insulin action in cultured hepatoma cells. (1984) (194)
Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models. (2011) (189)
Irs1 serine 307 promotes insulin sensitivity in mice. (2010) (185)
Insulin Receptor Substrate-1 is the Predominant Signaling Molecule Activated by Insulin-like Growth Factor-I, Insulin, and Interleukin-4 in Estrogen Receptor-positive Human Breast Cancer Cells* (1998) (178)
Exendin-4 Uses Irs2 Signaling to Mediate Pancreatic β Cell Growth and Function* (2006) (178)
SH2 domains exhibit high-affinity binding to tyrosine-phosphorylated peptides yet also exhibit rapid dissociation and exchange (1993) (173)
Molecular insights into insulin action and secretion (2002) (172)
Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells. (1993) (171)
Essential Role of Insulin Receptor Substrate-2 in Insulin Stimulation of Glut4 Translocation and Glucose Uptake in Brown Adipocytes* (2000) (171)
The Pleckstrin Homology Domain Is the Principle Link between the Insulin Receptor and IRS-1* (1996) (168)
Defective insulin secretion in pancreatic β cells lacking type 1 IGF receptor (2002) (166)
Calmodulin Activates Phosphatidylinositol 3-Kinase* (1997) (166)
IRS proteins and beta-cell function. (2001) (165)
Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation. (2004) (163)
Insulin Receptor Substrate-2 Binds to the Insulin Receptor through Its Phosphotyrosine-binding Domain and through a Newly Identified Domain Comprising Amino Acids 591786 (*) (1996) (163)
Pdx1 restores β cell function in Irs2 knockout mice (2002) (162)
The COOH-terminal Tyrosine Phosphorylation Sites on IRS-1 Bind SHP-2 and Negatively Regulate Insulin Signaling* (1998) (160)
Insulin Receptor Substrates Irs1 and Irs2 Coordinate Skeletal Muscle Growth and Metabolism via the Akt and AMPK Pathways (2010) (159)
Purification and partial sequence analysis of pp185, the major cellular substrate of the insulin receptor tyrosine kinase. (1991) (155)
Interleukins 2, 4, 7, and 15 Stimulate Tyrosine Phosphorylation of Insulin Receptor Substrates 1 and 2 in T Cells POTENTIAL ROLE OF JAK KINASES (*) (1995) (153)
Interleukin-4-mediated Protection of Primary B Cells from Apoptosis through Stat6-dependent Up-regulation of Bcl-xL* (2002) (151)
Regulating insulin signaling and β-cell function through IRS proteinsThis paper is one of a selection of papers published in this Special Issue, entitled Second Messengers and Phosphoproteins—12th International Conference. (2006) (150)
Human IL6 enhances leptin action in mice (2009) (149)
Activation of the phosphatidylinositol 3-kinase serine kinase by IFN-alpha. (1997) (148)
Response to Comment on "Brain IRS2 Signaling Coordinates Life Span and Nutrient Homeostasis" (2008) (145)
Kinetic properties and sites of autophosphorylation of the partially purified insulin receptor from hepatoma cells. (1984) (145)
YMXM motifs of IRS-1 define substrate specificity of the insulin receptor kinase. (1992) (145)
Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes. (2003) (145)
The Type I Interferon Receptor Mediates Tyrosine Phosphorylation of Insulin Receptor Substrate 2 (*) (1996) (144)
Pulsatile Portal Vein Insulin Delivery Enhances Hepatic Insulin Action and Signaling (2012) (139)
The Irs1 Branch of the Insulin Signaling Cascade Plays a Dominant Role in Hepatic Nutrient Homeostasis (2009) (138)
Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications. (2002) (137)
Association of IRS-1 with the insulin receptor and the phosphatidylinositol 3'-kinase. Formation of binary and ternary signaling complexes in intact cells. (1993) (137)
Requirement of protein kinase C zeta for stimulation of protein synthesis by insulin (1997) (134)
The IRS-2 gene on murine chromosome 8 encodes a unique signaling adapter for insulin and cytokine action. (1997) (133)
Tryptic activation of the insulin receptor. Proteolytic truncation of the alpha-subunit releases the beta-subunit from inhibitory control. (1988) (132)
The Fyn Tyrosine Kinase Binds Irs-1 and Forms a Distinct Signaling Complex during Insulin Stimulation (*) (1996) (130)
Myocardial Loss of IRS1 and IRS2 Causes Heart Failure and Is Controlled by p38α MAPK During Insulin Resistance (2013) (130)
Disruption of the SH2-B Gene Causes Age-Dependent Insulin Resistance and Glucose Intolerance (2004) (127)
Insulin receptor kinase domain autophosphorylation regulates receptor enzymatic function. (1992) (127)
Insulin receptor substrate proteins and diabetes (2004) (127)
Growth Hormone, Interferon-γ, and Leukemia Inhibitory Factor Utilize Insulin Receptor Substrate-2 in Intracellular Signaling* (1996) (126)
Involvement of Insulin Receptor Substrate 2 in Mammary Tumor Metastasis (2004) (126)
Characterization of the insulin receptor kinase purified from human placental membranes. (1983) (125)
Insulin stimulation of phosphatidylinositol 3-kinase activity maps to insulin receptor regions required for endogenous substrate phosphorylation. (1992) (125)
Janus Kinase-dependent Activation of Insulin Receptor Substrate 1 in Response to Interleukin-4, Oncostatin M, and the Interferons* (1997) (124)
Muscle-Specific IRS-1 Ser→Ala Transgenic Mice Are Protected From Fat-Induced Insulin Resistance in Skeletal Muscle (2008) (120)
Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. (1999) (119)
Defective insulin secretion in pancreatic beta cells lacking type 1 IGF receptor. (2002) (118)
A naturally occurring mutation of insulin receptor alanine 1134 impairs tyrosine kinase function and is associated with dominantly inherited insulin resistance. (1990) (118)
Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function. (2006) (117)
The IRS-pathway operates distinctively from the Stat-pathway in hematopoietic cells and transduces common and distinct signals during engagement of the insulin or interferon-alpha receptors. (1997) (114)
Receptor-mediated internalization of insulin requires a 12-amino acid sequence in the juxtamembrane region of the insulin receptor beta-subunit. (1990) (114)
The Pleckstrin Homology Domain in Insulin Receptor Substrate-1 Sensitizes Insulin Signaling (*) (1995) (114)
Targeted Disruption of ROCK1 Causes Insulin Resistance in Vivo* (2009) (113)
Differences in the sites of phosphorylation of the insulin receptor in vivo and in vitro. (1985) (110)
APPL1 Potentiates Insulin Sensitivity by Facilitating the Binding of IRS1/2 to the Insulin Receptor (2014) (110)
Genetic Deficiency of Glycogen Synthase Kinase-3β Corrects Diabetes in Mouse Models of Insulin Resistance (2008) (109)
Chronic activation of a designer G(q)-coupled receptor improves β cell function. (2013) (109)
Regulating insulin signaling and beta-cell function through IRS proteins. (2006) (109)
Insulin Receptor Substrate-2 Is Not Necessary for Insulin- and Exercise-stimulated Glucose Transport in Skeletal Muscle* (1999) (108)
Human Skeletal Muscle Insulin Receptor Substrate-1: Characterization of the cDNA, Gene, and Chromosomal Localization (1993) (108)
The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. (1998) (107)
The role of insulin receptor kinase domain autophosphorylation in receptor-mediated activities. Analysis with insulin and anti-receptor antibodies. (1992) (105)
Characterization of an endogenous substrate of the insulin receptor in cultured cells. (1987) (104)
Stat6 and IRS-2 Cooperate in Interleukin 4 (IL-4)-Induced Proliferation and Differentiation but Are Dispensable for IL-4-Dependent Rescue from Apoptosis (2002) (102)
Pdx1 restores beta cell function in Irs2 knockout mice. (2002) (102)
Perspective: The Insulin Signaling System-A Common Link in the Pathogenesis of Type 2 Diabetes. (2000) (101)
Nutrient-dependent and Insulin-stimulated Phosphorylation of Insulin Receptor Substrate-1 on Serine 302 Correlates with Increased Insulin Signaling* (2004) (100)
A defective intramolecular autoactivation cascade may cause the reduced kinase activity of the skeletal muscle insulin receptor from patients with non-insulin-dependent diabetes mellitus. (1989) (99)
Insulin receptors internalize by a rapid, saturable pathway requiring receptor autophosphorylation and an intact juxtamembrane region (1991) (99)
Predominance of tyrosine phosphorylation of insulin receptors during the initial response of intact cells to insulin. (1985) (98)
Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer. (1998) (98)
IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease. (2011) (98)
Suppression of Insulin Receptor Substrate 1 (IRS-1) Promotes Mammary Tumor Metastasis (2006) (98)
Insulin receptor substrate signaling suppresses neonatal autophagy in the heart. (2013) (97)
The insulin receptor juxtamembrane region contains two independent tyrosine/beta-turn internalization signals (1992) (96)
Insulin stimulates serine and tyrosine phosphorylation in the juxtamembrane region of the insulin receptor. (1993) (96)
YMXM motifs and signaling by an insulin receptor substrate 1 molecule without tyrosine phosphorylation sites (1996) (94)
The Drosophila insulin receptor activates multiple signaling pathways but requires insulin receptor substrate proteins for DNA synthesis (1996) (93)
The insulin receptor and its substrate: molecular determinants of early events in insulin action. (1993) (90)
The 60 kDa insulin receptor substrate functions like an IRS protein (pp60IRS3) in adipose cells. (1997) (89)
Structural and biochemical characterization of the KRLB region in insulin receptor substrate-2 (2008) (89)
Direct Autocrine Action of Insulin on β-Cells: Does It Make Physiological Sense? (2013) (88)
Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling. (1999) (87)
The Pleckstrin Homology and Phosphotyrosine Binding Domains of Insulin Receptor Substrate 1 Mediate Inhibition of Apoptosis by Insulin (1998) (85)
Insulin receptor substrate 1 mediates insulin and insulin-like growth factor I-stimulated maturation of Xenopus oocytes. (1993) (84)
Insulin-like growth factor I rapidly stimulates tyrosine phosphorylation of a Mr 185,000 protein in intact cells. (1987) (84)
Insulin receptor substrate-1 (IRS-1) expression in rat brain. (1994) (84)
Insulin binding and insulin-dependent phosphorylation of the insulin receptor solubilized from human erythrocytes. (1983) (84)
Insulin Receptor Substrates Are Essential for the Bioenergetic and Hypertrophic Response of the Heart to Exercise Training (2014) (83)
Direct visualization of the phosphorylated epidermal growth factor receptor during its internalization in A-431 cells (1987) (82)
The insulin receptor with phenylalanine replacing tyrosine-1146 provides evidence for separate signals regulating cellular metabolism and growth. (1990) (82)
Insulin signaling after exercise in insulin receptor substrate-2-deficient mice. (2002) (81)
Insulin Receptor Substrate 2 Is Essential for Maturation and Survival of Photoreceptor Cells (2005) (79)
Phosphorylation and dephosphorylation of the insulin receptor: evidence against an intrinsic phosphatase activity. (1984) (77)
Adapter Function of Protein-tyrosine Phosphatase 1D in Insulin Receptor/Insulin Receptor Substrate-1 Interaction (*) (1995) (76)
IRS Pleckstrin Homology Domains Bind to Acidic Motifs in Proteins* (1998) (76)
Insulin and Metabolic Stress Stimulate Multisite Serine/Threonine Phosphorylation of Insulin Receptor Substrate 1 and Inhibit Tyrosine Phosphorylation* (2014) (74)
Insulin-like Growth Factor I (IGF-I)-stimulated Pancreatic β-Cell Growth Is Glucose-dependent (1998) (73)
Phosphorylation of the insulin receptor substrate IRS-1 by casein kinase II. (1993) (72)
Increased protein kinase C activity is linked to reduced insulin receptor autophosphorylation in liver of starved rats. (1990) (71)
IRS2 integrates insulin/IGF1 signalling with metabolism, neurodegeneration and longevity (2014) (71)
The insulin receptor functions normally in Chinese hamster ovary cells after truncation of the C terminus. (1991) (70)
Islet-sparing effects of protein tyrosine phosphatase-1b deficiency delays onset of diabetes in IRS2 knockout mice. (2004) (70)
Insulin receptor substrate-2 binds to the insulin receptor through its phosphotyrosine-binding domain and through a newly identified domain comprising amino acids 591-786. (1996) (69)
Interferon-alpha engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3'-kinase. (1995) (68)
Tyrosine phosphorylation of the insulin receptor during insulin-stimulated internalization in rat hepatoma cells. (1989) (68)
Immunocytochemical detection of insulin receptor substrate-1 (IRS-1) in rat brain: colocalization with phosphotyrosine (1993) (67)
Insulin-stimulated oocyte maturation requires insulin receptor substrate 1 and interaction with the SH2 domains of phosphatidylinositol 3-kinase (1993) (66)
IRS-2 Deficiency Impairs NMDA Receptor-Dependent Long-term Potentiation (2011) (66)
IRS-4 Mediates Protein Kinase B Signaling during Insulin Stimulation without Promoting Antiapoptosis (2000) (65)
Tyr624 and Tyr628 in Insulin Receptor Substrate-2 Mediate Its Association with the Insulin Receptor* (1997) (65)
Signaling Pathways: The Benefits of Good Communication (2004) (65)
IRS‐2 mediates the antiapoptotic effect of insulin in neonatal hepatocytes (2004) (64)
IRS proteins and diabetic complications (2016) (63)
The Repression of IRS2 Gene by ATF3, a Stress-Inducible Gene, Contributes to Pancreatic β-Cell Apoptosis (2008) (62)
Phosphorylation of the insulin receptor in cultured hepatoma cells and a solubilized system. (1985) (61)
Role of Insulin Receptor Substrates and Protein Kinase C-ζ in Vascular Permeability Factor/Vascular Endothelial Growth Factor Expression in Pancreatic Cancer Cells* (2004) (60)
Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes. (1998) (60)
Heterologous Pleckstrin Homology Domains Do Not Couple IRS-1 to the Insulin Receptor* (1997) (60)
New frontiers in insulin receptor substrate signaling (1995) (60)
Regulation of insulin receptor internalization in vascular endothelial cells by insulin and phorbol ester. (1987) (60)
Inhibition of TNF-α Improves the Bladder Dysfunction That Is Associated With Type 2 Diabetes (2012) (59)
The dissociation and degradation of internalized insulin occur in the endosomes of rat hepatoma cells. (1990) (58)
Feedback regulation of hepatic gluconeogenesis through modulation of SHP/Nr0b2 gene expression by Sirt1 and FoxO1. (2011) (58)
The IRS-signalling system in insulin and cytokine action. (1996) (57)
Inactivating hepatic follistatin alleviates hyperglycemia (2018) (57)
The IRS-1 signaling system. (1994) (57)
The reciprocal stability of FOXO1 and IRS2 creates a regulatory circuit that controls insulin signaling. (2006) (55)
Genetic Inactivation of Pyruvate Dehydrogenase Kinases Improves Hepatic Insulin Resistance Induced Diabetes (2013) (54)
IRS2 signaling in LepR-b neurons suppresses FoxO1 to control energy balance independently of leptin action. (2012) (53)
Withers, D. J. et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900-904 (1998) (53)
Overexpression or ablation of JNK in skeletal muscle has no effect on glycogen synthase activity. (2004) (52)
Serine Phosphorylation Sites on IRS2 Activated by Angiotensin II and Protein Kinase C To Induce Selective Insulin Resistance in Endothelial Cells (2013) (52)
Phosphatase and Tensin Homolog Regulation of Islet Growth and Glucose Homeostasis* (2005) (51)
Insulin action at a molecular level – 100 years of progress (2021) (50)
Ca2+ regulates calmodulin binding to IQ motifs in IRS-1. (1996) (50)
Conformational changes in the alpha- and beta-subunits of the insulin receptor identified by anti-peptide antibodies. (1989) (50)
Interaction of p59fyn with interferon-activated Jak kinases. (1997) (49)
Inhibition of Insulin Signaling in Endothelial Cells by Protein Kinase C-induced Phosphorylation of p85 Subunit of Phosphatidylinositol 3-Kinase (PI3K)* (2011) (49)
Insulin-induced egr-1 and c-fos Expression in 32D Cells Requires Insulin Receptor, Shc, and Mitogen-activated Protein Kinase, but Not Insulin Receptor Substrate-1 and Phosphatidylinositol 3-Kinase Activation* (1996) (49)
7 The Insulin Receptor and Tyrosine Phosphorylation (1986) (47)
The juxtamembrane regions of the epidermal growth factor receptor and gp185erbB-2 determine the specificity of signal transduction (1991) (47)
Endotoxemia-mediated activation of acetyltransferase P300 impairs insulin signaling in obesity (2017) (47)
Autophosphorylation and kinase activity of insulin receptor in diabetic rats. (1986) (47)
Phosphorylation of glycolytic and gluconeogenic enzymes by the insulin receptor kinase (1987) (46)
Molecular mechanism(s) of burn-induced insulin resistance in murine skeletal muscle: role of IRS phosphorylation. (2005) (45)
Alterations in growth and apoptosis of insulin receptor substrate-1-deficient beta-cells. (2005) (44)
Cascade of autophosphorylation in the β‐subunit of the insulin receptor (1989) (44)
Tyrosine phosphorylation of the insulin receptor is not required for receptor internalization: studies in 2,4-dinitrophenol-treated cells. (1989) (42)
Tyrosine phosphorylations in vivo associated with v-fms transformation (1988) (42)
Rho-kinase/AMPK axis regulates hepatic lipogenesis during overnutrition (2018) (42)
Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells. (1998) (41)
Characterization of the Interleukin-4 Nuclear Activated Factor/STAT and Its Activation Independent of the Insulin Receptor Substrate Proteins (*) (1995) (41)
Insulin stimulates tyrosine phosphorylation of multiple high molecular weight substrates in Fao hepatoma cells. (1992) (40)
Interactive roles of Ras, insulin receptor substrate-1, and proteins with Src homology-2 domains in insulin signaling in Xenopus oocytes. (1994) (39)
Phosphorylation of Irs1 at SER-522 inhibits insulin signaling. (2007) (39)
Association of Insulin Receptor Substrate 1 (IRS-1) Y895 with Grb-2 Mediates the Insulin Signaling Involved in IRS-1-Deficient Brown Adipocyte Mitogenesis (2001) (39)
Compensatory alterations for insulin signal transduction and glucose transport in insulin-resistant diabetes. (1995) (37)
Mutations in the juxtamembrane region of the insulin receptor impair activation of phosphatidylinositol 3-kinase by insulin. (1991) (36)
Phosphorylation of insulin-like growth factor I receptor by insulin receptor tyrosine kinase in intact cultured skeletal muscle cells. (1988) (36)
Nonphosphorylatable substrate analogs selectively block autophosphorylation and activation of the insulin receptor, epidermal growth factor receptor, and pp60v-src kinases. (1989) (36)
Interaction of the insulin receptor kinase with serine/threonine kinases in vitro (1985) (35)
Cytoplasmic juxtamembrane region of the insulin receptor: a critical role in ATP binding, endogenous substrate phosphorylation, and insulin-stimulated bioeffects in CHO cells. (1991) (34)
Insulin-like Growth Factor I (IGF-I)-stimulated Pancreatic b-Cell Growth Is Glucose-dependent SYNERGISTIC ACTIVATION OF INSULIN RECEPTOR SUBSTRATE-MEDIATED SIGNAL TRANSDUCTION PATHWAYS BY GLUCOSE AND IGF-I IN INS-1 CELLS* (1998) (34)
IRS proteins and β-cell function (2001) (34)
Irs2 and Irs4 synergize in non-LepRb neurons to control energy balance and glucose homeostasis★ (2013) (33)
Insulin signaling and reduced glucocorticoid receptor activity attenuate postprandial gene expression in liver (2018) (33)
Abnormality of insulin binding and receptor phosphorylation in an insulin-resistant melanoma cell line (1984) (33)
Functional domains of the insulin receptor responsible for chemotactic signaling. (1994) (33)
The AKTion in non-canonical insulin signaling (2012) (32)
The insulin receptor substrate-1-related 4PS substrate but not the interleukin-2R gamma chain is involved in interleukin-13-mediated signal transduction. (1995) (32)
Insulin resistance in thermally-injured rats is associated with post-receptor alterations in skeletal muscle, liver and adipose tissue. (2004) (32)
G protein-coupled receptors (GPCRs) That Signal via Protein Kinase A (PKA) Cross-talk at Insulin Receptor Substrate 1 (IRS1) to Activate the phosphatidylinositol 3-kinase (PI3K)/AKT Pathway* (2016) (32)
Integrating metabolism and longevity through insulin and IGF1 signaling. (2013) (31)
Interaction of insulin receptor substrate-1 (IRS-1) with phosphatidylinositol 3-kinase: effect of substitution of serine for alanine in potential IRS-1 serine phosphorylation sites. (1998) (31)
The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic β cell growth (2021) (31)
Insulin Receptor Substrate 2 Plays Diverse Cell-specific Roles in the Regulation of Glucose Transport* (2005) (31)
Perspective: The insulin signaling system--a common link in the pathogenesis of type 2 diabetes. (2000) (30)
Insulin receptor substrate 1 rescues insulin action in CHO cells expressing mutant insulin receptors that lack a juxtamembrane NPXY motif (1995) (29)
Structure and function of tyrosine kinase receptors (1991) (29)
Irs2 inactivation suppresses tumor progression in Pten+/- mice. (2009) (29)
Specificity of Interleukin-2 Receptor γ Chain Superfamily Cytokines Is Mediated by Insulin Receptor Substrate-dependent Pathway* (2002) (29)
Stimulation via CD3-Ti but not CD2 induces rapid tyrosine phosphorylation of a 68-kDa protein in the human Jurkat T cell line. (1990) (28)
Insulin-dependent Tyrosine Phosphorylation of the vav Proto-oncogene Product in Cells of Hematopoietic Origin (*) (1995) (28)
Preparation and use of anti-phosphotyrosine antibodies to study structure and function of insulin receptor. (1991) (28)
Activation of the Phosphatidylinositol 3-Kinase Serine Kinase by 1 FNa ’ (2001) (27)
Serine 302 Phosphorylation of Mouse Insulin Receptor Substrate 1 (IRS1) Is Dispensable for Normal Insulin Signaling and Feedback Regulation by Hepatic S6 Kinase* (2016) (26)
Nerve Growth Factor Receptor TrkA, a New Receptor in Insulin Signaling Pathway in PC12 Cells* (2013) (26)
Insulin-like growth factor 2 and the insulin receptor, but not insulin, regulate fetal hepatic glycogen synthesis. (2010) (26)
Phosphatidylcholine Transfer Protein Interacts with Thioesterase Superfamily Member 2 to Attenuate Insulin Signaling (2013) (25)
Recombinant human müllerian inhibiting substance inhibits epidermal growth factor receptor tyrosine kinase. (1989) (25)
Insulin receptor substrate 1 (IRS‐1) plays a unique role in normal epidermal physiology (2007) (25)
Plasma insulin levels predict the development of atherosclerosis when IRS2 deficiency is combined with severe hypercholesterolemia in apolipoprotein E-null mice. (2007) (24)
The Insulin Receptor Protein Kinase (1985) (24)
Differential modulation of the tyrosine phosphorylation state of the insulin receptor by IRS (insulin receptor subunit) proteins. (1999) (23)
Human insulin receptors expressed in insulin-insensitive mouse fibroblasts couple with extant cellular effector systems to confer insulin sensitivity and responsiveness. (1989) (23)
Pertussis toxin inhibits autophosphorylation and activation of the insulin receptor kinase. (1991) (23)
Insulin-like growth factor-1 induces rapid tyrosine phosphorylation of the vav proto-oncogene product. (1996) (23)
Attenuation of Accumulation of Neointimal Lipid by Pioglitazone in Mice Genetically Deficient in Insulin Receptor Substrate-2 and Apolipoprotein E (2005) (22)
Down-regulation of Insulin Receptor Substrate 1 during Hyperglycemia Induces Vascular Smooth Muscle Cell Dedifferentiation* (2016) (21)
An Mr 180,000 protein is an endogenous substrate for the insulin-receptor-associated tyrosine kinase in human placenta. (1987) (21)
Tyrosine-kinase defect of the insulin receptor in cultured fibroblasts from patients with lipoatropic diabetes. (1989) (21)
Essential role of protein kinase Cζ in the impairment of insulin‐induced glucose transport in IRS‐2‐deficient brown adipocytes (2003) (21)
Elevated circulating follistatin associates with an increased risk of type 2 diabetes (2021) (20)
Coordinate Phosphorylation of Insulin-Receptor Kinase and Its 175,000-Mr Endogenous Substrate in Rat Hepatocytes (1991) (20)
Hyperglycemia induces vascular smooth muscle cell dedifferentiation by suppressing insulin receptor substrate-1–mediated p53/KLF4 complex stabilization (2018) (19)
THE MOLECULAR BASIS OF INSULIN ACTION (2007) (19)
Models of insulin action on metabolic and growth response genes (1992) (19)
Ablation of insulin receptor substrates 1 and 2 suppresses Kras-driven lung tumorigenesis (2018) (18)
Characterization of phorbol ester-stimulated serine phosphorylation of the human insulin receptor. (1994) (18)
Deletion of Irs2 causes reduced kidney size in mice: role for inhibition of GSK3β? (2010) (18)
Differentiation-dependent phosphorylation of a 175,000 molecular weight protein in response to insulin and insulin-like growth factor-I in L6 skeletal muscle cells. (1989) (18)
Insulin receptor substrate-2 in beta-cells decreases diabetes in nonobese diabetic mice. (2009) (18)
Decreased autophosphorylation of EGF receptor in insulin-deficient diabetic rats. (1988) (18)
Insulin stimulates tyrosine phosphorylation of its receptor beta-subunit in intact rat hepatocytes. (1987) (18)
Interaction of wild type and dominant-negative p55PIK regulatory subunit of phosphatidylinositol 3-kinase with insulin-like growth factor-1 signaling proteins. (1997) (17)
Phosphorylation of Forkhead Protein FoxO1 at S253 Regulates Glucose Homeostasis in Mice. (2019) (17)
The IRS2 Gly1057Asp variant is associated with human longevity. (2010) (17)
Foxo1 in hepatic lipid metabolism (2010) (16)
Metformin and insulin meet in a most atypical way. (2009) (16)
Separate domains of the insulin receptor contain sites of autophosphorylation and tyrosine kinase activity. (1987) (16)
Insulin receptor substrate‐2 is expressed in kidney epithelium and up‐regulated in diabetic nephropathy (2013) (15)
Analysis of compensatory beta-cell response in mice with combined mutations of Insr and Irs2. (2007) (14)
The Insulin Receptor Tyrosine Kinase (1990) (14)
Insulin receptor substrates differentially exacerbate insulin-mediated left ventricular remodeling. (2020) (13)
Common and Distinct Elements in Insulin and PDGF Signaling a (1995) (13)
Insulin receptor substrate-1 deficiency drives a proinflammatory phenotype in KRAS mutant lung adenocarcinoma (2016) (11)
Insulin action and type 2 diabetes: lessons from knockout mice: (1999) (11)
Myocardial Loss of IRS1 and IRS2 Causes Heart Failure and Is Controlled by p38a MAPK During Insulin (2013) (11)
Trimeprazine increases IRS2 in human islets and promotes pancreatic β cell growth and function in mice. (2016) (10)
Diabetes forum: Extreme makeover of pancreatic α-cells (2010) (10)
The IRS.I signaling system (1994) (10)
REGULATION OF INSULIN/IGF-1 SIGNALING BY PROTEASOME-MEDIATED DEGRADATION OF IRS-2 (2001) (10)
Phosphatidylinositol 3 kinase is activated by insulin (1990) (10)
Regulation of protein synthesis by insulin through IRS-1. (2001) (9)
Paraventricular, subparaventricular and periventricular hypothalamic IRS4-expressing neurons are required for normal energy balance (2020) (9)
The Structure and Function of p55 Reveal a New Regulatory Subunit for Phosphatidylinositol 3-Kinase (1995) (8)
A Specific Increased Expression of Insulin Receptor Substrate 2 in Pancreatic -Cell Lines Is Involved in Mediating Serum-Stimulated -Cell Growth (1998) (8)
IRS1Ser³⁰⁷ phosphorylation does not mediate mTORC1-induced insulin resistance. (2014) (8)
Pdx 1 restores β cell function in Irs 2 knockout mice (2002) (7)
The role of receptor kinase activity and the NPEY960 motif in insulin-accelerated receptor-mediated insulin internalization. (1996) (7)
Insulin receptor substrate 1, but not IRS2, plays a dominant role in regulating pancreatic alpha cell function in mice (2021) (7)
Mechanisms of Insulin Action (2012) (7)
The role of hepatokines in NAFLD. (2023) (7)
Dysregulation of IRS-proteins causes insulin resistance and diabetes (2000) (6)
FoxO1 suppresses Fgf21 during hepatic insulin resistance to impair peripheral glucose utilization and acute cold tolerance (2021) (6)
Epidermal growth factor stimulated phosphorylation of a 120-kilodalton endogenous substrate protein in rat hepatocytes. (1990) (6)
Phosphorylation of the solubilized insulin receptor by the gene product of the Rous sarcoma virus, pp60src (1984) (5)
Chapter 33 – The Mechanisms of Insulin Action (2016) (5)
IRS 2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease (2018) (5)
Early biochemical events in insulin-stimulated fluid phase endocytosis. (1999) (5)
Irs2 deficiency alters hippocampus-associated behaviors during young adulthood. (2021) (5)
Downregulation of hepatic ceruloplasmin ameliorates NAFLD via SCO1-AMPK-LKB1 complex (2022) (4)
Irs 2 and Irs 4 synergize in non-LepRb neurons to control energy balance and glucose homeostasis # (2014) (4)
Purification and Partial Sequence Analysis of pp 185 , the Major Cellular Substrate of the Insulin Receptor Tyrosine Kinase * (2001) (4)
Binding kinetics of mutated insulin receptors in transfected cells grown in suspension culture: application to the Tyr----Phe 960 insulin receptor mutant. (1989) (4)
kNOXing on the door of selective insulin resistance. (2012) (4)
The P300 acetyltransferase inhibitor C646 promotes membrane translocation of insulin receptor protein substrate and interaction with the insulin receptor (2022) (4)
Breathing Room: The (Un)Natural History of Adipose Microhypoxia and Insulin Resistance (2009) (4)
TAZ inhibits GR and coordinates hepatic glucose homeostasis in normal physiologic states (2020) (3)
Deletion of Irs 2 Causes Reduced Kidney Size in Mice : Role for Inhibition of GSK 3 β ? (2010) (3)
Abstract 3559: Insulin Receptor Substrates (IRS) Signaling are Essential Regulators of Mitochondrial Function and Cardiomyocyte Survival (2008) (3)
Differential Regulation of Insulin Receptor Substrate-2 and Mitogen-Activated Protein Kinase Tyrosine Phosphorylation by Phosphatidylinositol 3-Kinase Inhibitors in SH-SY5Y Human Neuroblastoma Cells* * This work was supported by NIH Grants R29-NS-32843 and R01-NS-36778, grants from the American Diab (1998) (3)
Abstract 3992: Insulin Receptor Substrates (IRS) are Critical Regulators of Autophagy and Cardiomyocyte Survival (2009) (3)
TAZ inhibits glucocorticoid receptor and coordinates hepatic glucose homeostasis in normal physiological states (2021) (3)
Early biochemical events in insulin-stimulated fluid phase endocytosis. (1999) (3)
Section 4 :-Cell Mass and Function in Type 2 Diabetes IRS Proteins and-Cell Function (2001) (3)
Socs1 Induces Insulin Resistance by Promoting Ubiquitin-Mediated Degradation of IRS1 and IRS2 (2002) (2)
Alterations in growth and apoptosis of IRS-1 deficient beta-cells (2005) (2)
Activation of liver and muscle insulin receptor tyrosine kinase activity during in vivo insulin administration in rats (1990) (2)
Receptor Tyrosine Kinases and the Insulin Signaling System (2017) (2)
284 UROTHELIUM-RELEASED ATP CONTRIBUTES TO BLADDER DYSFUNCTION IN TYPE 2 DIABETES (2013) (2)
Erratum: Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth (Journal of Clinical Investigation (2006) 116 (101-114) DOI: 10.1172/JCI25735) (2006) (1)
282-LB: Dysregulated FGF21 Links Hepatic Insulin Resistance to Dysfunctional BAT (2019) (1)
Correction for Long et al., “Insulin Receptor Substrates Irs1 and Irs2 Coordinate Skeletal Muscle Growth and Metabolism via the Akt and AMPK Pathways” (2017) (1)
Longevity: Mapping the path to a longer life (2015) (1)
Transcription Factor FoxO1 Mediates the Survival of Photoreceptors (2006) (1)
Inhibition of insulin signaling by protein kinase C (2011) (1)
Mechanism of Insulin Action (2016) (1)
Disruptionof IRS-2 causes type 2 diabetes inmice (1998) (1)
Publisher Correction: Inactivating hepatic follistatin alleviates hyperglycemia (2018) (1)
Body image as a visuomotor transformation device revealed in adaptation to reversed vision (1)
IRS-Protein Scaffolds and Insulin/IGF Action in Central and Peripheral Tissues (2010) (1)
Serine Phosphorylation Sites on IRS2 by Angiotensin II and PKC Activated to Induce 1 (2013) (1)
Insulin-Stimulated Phosphorylation of IRS-1 on Ser302 Correlates with Enhanced Insulin Signaling (2004) (1)
IRS-2 is a Common Element in Peripheral Insulin Signaling and β-Cell Function (2000) (1)
1375 BLADDER DYSFUNCTION ASSOCIATED WITH TYPE 2 DIABETES IS IMPROVED BY INHIBITION OF INFLAMMATORY AND APOPTOTIC MEDIATORS (2011) (0)
500 COMBINATION OF METFORMIN AND INHIBITION OF TNF-A REVERSE THE BLADDER DYSFUNCTION ASSOCIATED WITH TYPE 2 DIABETES (2012) (0)
Tumorigenesis and Neoplastic Progression Irs 2 Inactivation Suppresses Tumor Progression in Pten / Mice (2010) (0)
Molecular Mechanisms of Signal Transduction by Tyrosine Kinase Receptors (1993) (0)
Modulateurs de l'irs (2003) (0)
Insulin signaling in combination with reduced glucocorticoid activity attenuate post-prandial gene expression in liver (2018) (0)
Inactivating hepatic follistatin alleviates hyperglycemia (2018) (0)
Paraventricular, subparaventricular and periventricular hypothalamic IRS4-expressing neurons are required for normal energy balance (2020) (0)
Copper restoration by liver Ceruloplasmin ablation ameliorates NAFLD via SCO1-AMPK-LKB1 complex (2021) (0)
Translational control at the mRNA-binding step (1997) (0)
multisite phosphorylation of IRS-1. Pleiotropic insulin signals are engaged by (2013) (0)
1835-P: Deletion of Insulin Receptor Substrate 2 in AGRP Neurons Causes Beta-Cell Dysfunction (2019) (0)
Author response: TAZ inhibits glucocorticoid receptor and coordinates hepatic glucose homeostasis in normal physiological states (2021) (0)
O-32: p55PIK is expressed and required during neuronal differentiation (2009) (0)
MP17-14 CORRECTION OF HYPERGLYCEMIA AND HYPERINSULINEMIA BY GENETIC MODIFICATION RESTORES BLADDER DYSFUNCTION ASSOCIATED WITH TYPE 2 DIABETES (2014) (0)
P-2: Insulin and food intake increase neuronal phosphotyrosine levels in the arcuate nucleus of the rat hypothalamus (2009) (0)
JNK Works as a Negative Feedback Inhibitor of Insulin Action (2002) (0)
IRS1Ser307 PHOSPHORYLATION DOES NOT MEDIATE mTORC1- INDUCED INSULIN RESISTANCE (2014) (0)
O-25: Purification and cloning of IRS-2 reveals the molecular bases of IRS-proteins in insulin and cytokine signaling (2009) (0)
O-43: Multiple pathways for insulin-induced egr-1 expression (2009) (0)
O-27: IRS-2 binds to the insulin receptor through its PTB domain and through a newly identified domain comprising amino acids 591 to 786 (2009) (0)
Rapid internalization of the insulin receptor in rat hepatoma cells (1987) (0)
Metabolic Dysfunction within Brown Adipose Tissue and Skeletal Muscle Caused by Complete Hepatic Insulin Resistance Is Reversible by FGF-21 Treatment (2018) (0)
Circulating follistatin predicts type 2 diabetes risk (2020) (0)
O-47: Mechanisms of TNF-α induced insulin resistance (2009) (0)
Potentiation in Hippocampal CA1 Pyramidal Neurons Caffeine-Mediated Presynaptic Long-Term (2015) (0)
Phosphatidylinositol pathways in growth and transformation (1990) (0)
has no effect on glycogen synthase activity Overexpression or ablation of JNK in skeletal muscle (2005) (0)
MetastasisPromotes Mammary Tumor Suppression of Insulin Receptor Substrate (2014) (0)
How insulin works - Shedding some light into the black box (1989) (0)
Impairment of insulin-stimulated glucose utilization is associated with burn-induced insulin resistance in mouse muscle by hyperinsulinemic-isoglycemic clamp (2020) (0)
Endotoxemia-mediated activation of acetyltransferase P300 impairs insulin signaling in obesity (2017) (0)
Insulin Receptor Substrate-2 in (cid:1) -Cells Decreases Diabetes in Nonobese Diabetic Mice (2009) (0)
Foxo1-Ser253 Phosphorylation Regulates Glucose Homeostasis in Mice (2018) (0)
Function of the Insulin Receptor Kinase in the Intact Cell (2018) (0)
442 A GENETIC ANIMAL MODEL FOR BLADDER DYSFUNCTION ASSOCIATED WITH TYPE 2 DIABETES (2010) (0)
O-28: Characterization of IRS-1 molecules containing single SH2-protein binding determinants (2009) (0)
Cyclins D2 and D1 Are Essential for Postnatal Pancreatic (cid:2) -Cell Growth (2005) (0)
Insulin-Stimulat ed OocyteMaturation Requires Insulin Receptor Substrate 1andInteraction withtheSH2Domains ofPhosphatidylinositol 3-Kinase (1993) (0)
Abstract 177: Insulin Resistance and Mechanisms of Heart Failure (2013) (0)
CHAPTER 72 – IRS-Protein Scaffolds and Insulin/IGF Action (2003) (0)
Regulation of Metabolism and Reproduction Through the Insulin Receptor Substrate Protein Signaling System (2002) (0)
IRS-2 failure causes multisystem pathophysiology (2001) (0)
P-49: Interaction of IRS molecules with a novel 19 kD protein that carries an armadillo motif (2009) (0)
The Relationship Between the Insulin Receptor Substrates and Metabolic Disease (2008) (0)
O-42: Mitogenic signalling by insulin in a T-cell lymphoma, the LB cell line, devoid of IGF-I receptors: evidence for the lack of involvement of the RAS-MAP kinase pathway and for a possibly novel IRS-like molecule (2009) (0)
Fasting Blood Glucose Concentration at 6 and 8 wk of Age in Either WT, Gsk-3β+/−, Irs2−/−, or Gsk-3β+/−Irs2−/− Mice (2008) (0)
Erratum. Inhibition of TNF-α Improves the Bladder Dysfunction That Is Associated With Type 2 Diabetes. Diabetes 2012;61:2134–2145 (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Morris F. White?

Morris F. White is affiliated with the following schools:

Morris F. White's Academic­Influence.com Rankings

Morris F. White's Degrees

Why Is Morris F. White Influential?

Morris F. White's Published Works

Published Works

What Schools Are Affiliated With Morris F. White?

Morris F. White's AcademicInfluence.com Rankings